S. Klauke

Platelet-leucocyte adhesion markers before and after the initiation of antiretroviral therapy with HIV protease inhibitors.

S. Staszewski, P. Gute, S. Harder, 2008, Journal of Antimicrobial Chemotherapy.

Significant effects of tipranavir on platelet aggregation and thromboxane B2 formation in vitro and in vivo.

P. Gute, S. Harder, C. Angioni, 2007, The Journal of antimicrobial chemotherapy.

A comparison of the steady-state pharmacokinetics of nevirapine in men, nonpregnant women and women in late pregnancy.

M. Kurowski, S. Staszewski, P. Gute, 2006, British journal of clinical pharmacology.

Tenofovir comedication does not impair the steady-state pharmacokinetics of ritonavir-boosted atazanavir in HIV-1-infected adults

S. Staszewski, S. Harder, T. Lutz, 2007, European Journal of Clinical Pharmacology.

Pharmacokinetics and tolerability of a combination of indinavir, lopinavir and ritonavir in multiply pretreated HIV-1 infected adults.

M. Kurowski, S. Staszewski, S. Harder, 2006, European journal of medical research.

HIV Drug Susceptibility and Treatment Response to Mega-Haart Regimen in Patients from the Frankfurt HIV Cohort

K. Hertogs, B. Larder, S. Bloor, 2000, Antiviral therapy.